Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Indian J Ophthalmol ; 2014 Sept ; 62 (9): 966-968
Article in English | IMSEAR | ID: sea-155762

ABSTRACT

We report a case of large histopathologically proven melanocytoma of the ciliary body in a 15‑year‑old male, presented with rapid extraocular growth following incisional biopsy with scleral patch graft. We chose brachytherapy with Ruthenium 106 plaque over enucleation as the later was refused by the parents. The initial apical height of the tumor was 14.2 mm on ultrasonography. Two weeks after brachytherapy, the mass regressed to a size of 8.1 mm and 1 year later to 6.7 mm. This is the first case report showing the response of brachytherapy to ciliary body melanocytoma, which results in ocular and visual acuity salvation with considerable decreased in size of the tumor. The authors conclude that brachytherapy is an option in the management of non‑resectable melanocytoma of the ciliary body.

2.
Indian J Ophthalmol ; 2014 Sept ; 62 (9): 966-968
Article in English | IMSEAR | ID: sea-155761

ABSTRACT

We report a case of large histopathologically proven melanocytoma of the ciliary body in a 15‑year‑old male, presented with rapid extraocular growth following incisional biopsy with scleral patch graft. We chose brachytherapy with Ruthenium 106 plaque over enucleation as the later was refused by the parents. The initial apical height of the tumor was 14.2 mm on ultrasonography. Two weeks after brachytherapy, the mass regressed to a size of 8.1 mm and 1 year later to 6.7 mm. This is the first case report showing the response of brachytherapy to ciliary body melanocytoma, which results in ocular and visual acuity salvation with considerable decreased in size of the tumor. The authors conclude that brachytherapy is an option in the management of non‑resectable melanocytoma of the ciliary body.

SELECTION OF CITATIONS
SEARCH DETAIL